Zantac (ranitidine) was a blockbuster over-the-counter and prescription medication for treating heartburn, acid reflux, and ulcers. But over the past few years, there has been increasing alarm over a possible cancer link to the drug, triggering a series of Zantac lawsuits against the drug manufacturers.
This article discusses the legal foundation of Zantac lawsuits, the scientific evidence driving the claims, where the cases stand in California and across the country, and what injured patients should know if they’re considering making a claim.
What Is Zantac?
Zantac is the brand name for ranitidine, a type of histamine-2 (H2) blocker. It works by reducing the amount of acid produced in the stomach and was widely used to treat:
- Heartburn and indigestion
- Gastroesophageal reflux disease (GERD)
- Stomach and intestinal ulcers
- Zollinger-Ellison syndrome
It was available in both prescription and over-the-counter forms and had been on the market for decades. At one point, it was one of the world’s top-selling drugs.
Why Was Zantac Recalled?
In 2019, independent testing revealed that ranitidine products could contain high levels of NDMA (N-Nitrosodimethylamine), a probable human carcinogen. NDMA is a chemical classified by the World Health Organization (WHO) and the U.S. Environmental Protection Agency (EPA) as potentially cancer-causing in humans.
The testing showed that:
- NDMA levels in some Zantac samples were thousands of times higher than the FDA’s acceptable daily limit
- NDMA could form over time or when the drug was stored at high temperatures
- The risk was not just a contamination issue but an inherent chemical instability in ranitidine itself
As a result, the FDA requested a voluntary recall of all ranitidine products in April 2020, effectively pulling Zantac off pharmacy shelves across the U.S.
What Cancers Are Allegedly Linked to Zantac?
Plaintiffs in Zantac lawsuits allege that long-term use of the drug caused or contributed to the development of several types of cancer, including:
- Bladder cancer
- Stomach (gastric) cancer
- Colorectal cancer
- Esophageal cancer
- Liver cancer
- Pancreatic cancer
- Prostate cancer
- Lung cancer (in non-smokers)
- Breast cancer
These claims are based on the assertion that exposure to high levels of NDMA over time significantly increases the risk of developing these cancers.
Basis for Zantac Lawsuits
Zantac lawsuits are primarily product liability claims, focusing on how the drug was designed, tested, marketed, and labeled. Plaintiffs generally allege:
1. Defective Design
The lawsuits claim that ranitidine is inherently unstable and prone to breaking down into NDMA, especially under normal storage conditions. This design defect allegedly made the drug unreasonably dangerous for consumers.
2. Failure to Warn
Plaintiffs argue that manufacturers failed to provide adequate warnings about the potential cancer risks, despite knowing — or having reason to know — that Zantac could form NDMA over time.
3. Misrepresentation and Fraud
Some lawsuits accuse drugmakers of misleading marketing practices, including claiming that Zantac was safe for daily and long-term use without disclosing the potential risks.
4. Negligence
Lawsuits also assert that manufacturers were negligent in researching, testing, and monitoring the safety of ranitidine, particularly in light of earlier studies raising concerns about NDMA formation.
Who Are the Defendants?
Numerous pharmaceutical companies have been named in Zantac lawsuits, including:
- Sanofi
- GlaxoSmithKline (GSK)
- Pfizer
- Boehringer Ingelheim
- Generic drug manufacturers
- Retailers and pharmacies that sold the product
Each may bear liability depending on their role in the manufacture, distribution, or sale of Zantac products.
Status of Zantac Litigation
Zantac litigation has grown into one of the largest mass torts in U.S. history. Thousands of individual cases have been filed across the country, including:
- State court lawsuits, including many filed in California
- Multidistrict Litigation (MDL) in federal court (originally in the Southern District of Florida)
In late 2022, the federal MDL judge dismissed all generic ranitidine claims in federal court due to insufficient scientific evidence linking Zantac to cancer. However, state-level cases — including many in California, Illinois, and Delaware — are still active and moving forward.
California courts, in particular, are continuing to evaluate the causation evidence, and some cases may proceed to trial in the coming years.
Who Is Eligible to File a Zantac Lawsuit?
To be eligible, a plaintiff generally must show:
- Regular use of Zantac or ranitidine products for a prolonged period (typically several months or years)
- A subsequent diagnosis of one of the cancers allegedly linked to NDMA exposure
- No significant prior exposure to other known NDMA sources (e.g., industrial workplaces, contaminated water)
- A reasonable timeline between Zantac use and cancer diagnosis
- Sufficient medical documentation and prescription/OTC purchase history
Family members may also file wrongful death lawsuits if a loved one died from a qualifying cancer after taking Zantac.
What Compensation Is Available?
Successful plaintiffs in Zantac lawsuits may be entitled to various forms of compensation, including:
- Medical expenses (past and future)
- Lost income and reduced earning capacity
- Pain and suffering
- Emotional distress
- Wrongful death damages for surviving family members
- Punitive damages (in cases of willful misconduct or concealment)
Exact compensation will depend on the facts of each case, including the severity of illness, the degree of negligence, and the available evidence.
How to File a Zantac Lawsuit
Take a look on how you can file a Zantac Lawsuit:
Step 1: Consult a Product Liability Attorney
Given the complexity of pharmaceutical litigation, it is essential to speak with a lawyer experienced in dangerous drug lawsuits. Many attorneys handling Zantac cases work on a contingency basis, meaning no upfront fees are required.
Step 2: Document Your Use and Diagnosis
To build a strong case, you’ll need:
- Proof of Zantac use (prescriptions, receipts, medical records)
- Medical records showing your cancer diagnosis and treatment
- A detailed history of other exposures to risk factors, including family history
Step 3: File a Complaint
Your attorney will prepare and file a civil complaint in the appropriate court. Depending on your jurisdiction, your case may be consolidated with others or proceed individually.
Step 4: Settlement or Trial
Many Zantac cases may be resolved through negotiated settlements, while others may go to trial. Even if federal claims have been dismissed, state-level lawsuits remain viable.
About the Author
Neil Bhartia
Neil Bhartia isn’t your typical, stuffy attorney that you see on TV. While some have their sights exclusively on money and treat their clients like a number, Neil takes a personal interest in every single client he has. As an empath, Neil understands that people that seek legal help are typically in an involuntary, and stressful situation, and he goes out of his way to diffuse the stress and educate clients on each every detail of the legal process.
